{
  "id": "new-2026-ml6zqju7",
  "type": "new-test",
  "status": "applied",
  "createdAt": "2026-02-03T19:27:41.551Z",
  "createdBy": "daemon",
  "reviewedAt": "2026-02-05T20:30:00.000Z",
  "reviewedBy": "claude",
  "appliedAt": "2026-02-05T20:30:00.000Z",
  "rejectionReason": null,
  "testData": {
    "name": "Quest Diagnostics Flow Cytometry MRD Blood Test for Myeloma",
    "vendor": "Quest Diagnostics",
    "category": "Molecular Residual Disease",
    "description": "Novel flow cytometry MRD blood test enabling ultrasensitive detection of residual disease in myeloma, as sensitive as next-generation sequencing with five-day specimen stability",
    "launchDate": "2026-02-02"
  },
  "source": "https://newsroom.questdiagnostics.com/press-releases",
  "sourceTitle": "Quest Diagnostics: Launches Quest Diagnostics Flow Cytometry MRD Blood Test for Myeloma",
  "confidence": 0.7,
  "snippet": "Novel flow cytometry MRD blood test enabling ultrasensitive detection of residual disease in myeloma, as sensitive as next-generation sequencing with five-day specimen stability"
}